Posts by B-BIC

Specialist Series: Your Elevator Pitch: Don’t leave home without it!

Written by Melissa Marshall Have you ever walked away from a conversation about your work with an important individual and thought, “Darn. I wish I would have explained that better or said it this way instead…”? Or maybe you had an unexpected interaction with someone who asked about your work and you just started rambling…

Read More

NEW AWARD: CONGRATULATIONS DR. BEN MATTHEWS

RECIPIENT:  Dr. Ben Matthews TITLE: PR1P, an inhaled novel short peptide for emphysema TYPE OF AWARD:  PILOT INSTITUTION: Boston Children’s Hospital DESCRIPTION:  Emphysema is a chronic progressive pulmonary disease characterized by destruction of alveoli leading to impaired lung function that threatens human health worldwide. Disease progression is due in part to dysregulation of the survival factor Vascular Endothelial Growth Factor (VEGF). …

Read More

Specialist Series: Patents

What is a U.S. patent? A patent is a property right. The property right granted is an exclusionary right, i.e., the right to exclude others from making, using, offering for sale, or selling an invention. In the US, generally this exclusionary right lasts for 20 years from the date of the initial filing of an…

Read More

B-BIC Partner Update: PLATELET BIOGENESIS RAISES A $10 MILLION SERIES A FINANCING LED BY QIMING US HEALTHCARE FUND

BOSTON, Mass. (June 8, 2017) – Platelet BioGenesis, a biotech startup developing a process to produce life-saving human platelets from stem cells for therapeutic applications, announced it has successfully raised $10 million in Series A financing. The round was led by Qiming US Healthcare Fund and included Vivo Capital, VI Ventures, Adena Partners, eCoast Angels,…

Read More

NEW AWARD: CONGRATULATIONS DR. MICHAEL SWEENEY!

RECIPIENT:  Dr. Michael Sweeney TITLE: SQPAN TYPE OF AWARD:  PILOT INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:  Cardiac resynchronization therapy (CRT) is an electrical therapy using multi-site cardiac pacing to re-time the asynchronous contraction sequence of the failing heart on a beat-to-beat basis. Worldwide randomized clinical trials have consistently demonstrated that effective CRT induces reverse ventricular remodeling, which is followed…

Read More

NEW AWARD: CONGRATULATIONS DR. PAUL YU!

RECIPIENT:  Dr. Paul Yu TITLE: Molecular Imaging of Dysregulated Angiogenesis in Pulmonary Arterial Hypertension TYPE OF AWARD:  DRIVE INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:   Pulmonary arterial hypertension (PAH) is a disorder of elevated pulmonary vascular resistance characterized by progressive remodeling and obliteration of resistance-determining vessels of the pulmonary circulation. Despite current therapies, transplant-free survival…

Read More

NEW AWARD: CONGRATULATIONS DR. JILL GOLDSTEIN!

RECIPIENT:  Dr. Jill Goldstein TITLE: Development of an electroceutical for treatment of comorbidity between hypertension and major depression. TYPE OF AWARD:  DRIVE INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:  Hypertension is a leading cause of morbidity and mortality in the United States with an overall prevalence of approximately 29%, corresponding to 70 million of Americans. Despite the benefits…

Read More

FAQ: B-BIC APPLICATION PROCESS

  Who can apply for B-BIC grants? Anyone holding a faculty appointment at a B-BIC member institution may apply for a B-BIC grant. May I submit more than one application? Applicants may submit more than one proposal to both the Pilot and DRIVE programs.  However, each application must have a distinct set of aims and…

Read More

Tips & Tricks: Customer Research Basics

The “build it and they will come” approach may have worked for Steven Jobs at Apple but does not work for most new products.  For us mere mortals, it is important to conduct customer research before proceeding too far with a new idea.  You want to know if there is a market for your product…

Read More

Specialist Series: What is a “Venture Syndicate” ?

By Jay Knowles An investor syndicate generally consists of three of four investors who have the funds to take the company from idea stage through to clinical proof of concept.  Investors may not put all of the investment in upfront (so that they have a little more control over the flow of funds), and they…

Read More